At this point any PR would be refreshing. It would be nice to be brought up to date on PIMD activities, the Diabetes Program, the Physician Dispensing Program, the additional pharmacy(s) mentioned in a PR two months ago, and of course, RapiMeds. May revenues should exceed the $3.5M reported for April. And with the new cost efficiencies implemented, the profitability should be increased. It's time for the pps to respond to the revenues being generated.